Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
GALNT14 encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. Additionally we are shipping GALNT14 Proteins (10) and and many more products for this protein.
Showing 10 out of 72 products:
Human Polyclonal GALNT14 Primary Antibody for IF (p), IHC (p) - ABIN1713802
Yang, Li, Zhang: Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer. in Biomedicine & pharmacotherapy 2016
Cow (Bovine) Polyclonal GALNT14 Primary Antibody for WB - ABIN2783927
Xu, Chen, Zhang, Gong, Wu, Wang: Correlation between hand and total body bone density in normal Chinese children. in Bone 2007
Show all 2 Pubmed References
Silencing of GALNT14 in osterix-overexpressed cells restored the decreased chemosensitivity. Conversely, overexpression of GALNT14 in osterix-knockdown cells abrogated the increased chemosensitivity in breast cancer cells.
The analysis showed that the "TT" genotype was associated with unfavorable overall survival (OS, P = 0.009).
miR-125a functions as tumor suppressor in ovarian cancer by targeting GALNT14.
GALNT14 genotypes were significantly associated with clinical outcomes of transcatheter arterial chemoembolization.
Expression of GalNAc-T14 or HOXB9 was strongly correlated with reduced recurrence-free survival in lung adenocarcinomas.
Recurrence of mutation suggests GALNT14 as a novel gene potentially involved in neuroblastoma predisposition.
GALNT14 stimulates MMP-2 expression.
GALN14 genotype (rs9679162) was an effective predictor for therapeutic outcome in advanced hepatocellular carcinoma (HCC) patients treated by FMP chemotherapy.
Studies demonstrate that IGFBP-3 and GalNAc-T14 are colocalized in MCF-7 cells, and confirmed the interaction between IGFBP-3 and GalNAc-T14; these results reveal a minimal region of GalNAc-T14 that was sufficiently bound to the full-length IGFBP-3.
Results provide evidence that GalNAc-T14 may be a potential biomarker for breast cancer by immunohistochemistry.
GALNT14 and FUT3/6 H-scores were significantly higher in non-small cell lung cancer cell lines sensitive to dulanermin and drozitumab versus resistant cell lines
cloning and characterization; results provide evidence that pp-GalNAc-T14 is a new member of the pp-GalNAc-T family and suggest that it may be involved in the O-glycosylation in kidney
The role of GalNAc-T14 as an intracellular mediator of the effects of IGFBP-3 need to be verified in future studies.
GALNT14 may be involved in regulating the apoptotic action of IGFBP-3.
This gene encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. These enzymes catalyze the transfer of N-acetyl-D-galactosamine (GalNAc) to the hydroxyl groups on serines and threonines in target peptides. The encoded protein has been shown to transfer GalNAc to large proteins like mucins. Multiple transcript variants encoding different isoforms have been found for this gene.
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14)
, polypeptide N-acetylgalactosaminyltransferase 14
, polypeptide N-acetylgalactosaminyltransferase 14-like
, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14
, polypeptide GalNAc transferase 14
, pp-GaNTase 14
, protein-UDP acetylgalactosaminyltransferase 14
, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T10
, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T14
, polypeptide N-acetylgalactosaminyltransferase 15